News
Alar Pharmaceuticals Inc. (Alar, TPEx:6785), a clinical-stage pharmaceutical company dedicated to the development of long-acting injectables to treat CNS disorders, today announced the dosing of ...
Contacts The Schall Law Firm Brian Schall, Esq. www.schallfirm.com Office: 310-301-3335 [email protected] ...
Law Offices of Howard G. Smith announces an investigation on behalf of Alarum Technologies Ltd. (“Alarum” or the “Company”) (NASDAQ: ALAR) investors c ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback